The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 126.50
Bid: 125.00
Ask: 128.00
Change: 4.50 (3.69%)
Spread: 3.00 (2.40%)
Open: 122.00
High: 126.50
Low: 122.00
Prev. Close: 122.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Fundraising

21 Dec 2011 14:00

RNS Number : 4326U
Transense Technologies PLC
21 December 2011
 



Transense Technologies plc (the "Company")

 

21 December 2011

 

Result of Fundraising - £1,332,696 raised

 

The Company is pleased to report that it has received subscriptions under the Offer to Warrant holders for 22,243,240 Subscription Shares and accordingly will issue 11,121,606 Bonus Shares. The Company has also taken the opportunity, in response to investor demand, to issue a further 11,058,333 new ordinary shares of 1p each ("Ordinary Shares") at 3 pence per share to new and existing investors to raise, in aggregate, £1,332,696 (before expenses).

 

As previously announced, the proceeds of the Fundraising will be used to further develop the Company's strategy, and in particular to accelerate the pace at which it addresses the opportunities arising within the IntelliSAW division, and for general working capital purposes.

 

The new Ordinary Shares (including the Bonus Shares) to be issued pursuant to the Fundraising will be credited as fully paid and will rank pari passu with the existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of their issue.

 

The Company will apply for admission of the new Ordinary Shares to be traded on the AIM market of the London Stock Exchange. It is expected that Admission will take place and that trading will commence on 29 December 2011.

 

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following completion of the Fundraising will consist of 176,665,346 Ordinary Shares with one voting right per share. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

Capitalised terms used, but not defined in this announcement, have the same meanings as set out in the announcement released by the Company on 21 November 2011.

The Chairman, David Kleeman, said:

"We are very pleased by the level of support shown by shareholders in these challenging economic and market conditions. The Board believes that supported by the proceeds from the Fundraising, the Company is well on its way to generating significant income from its new revenue channels."

 

Contacts:

 

Transense Technologies PLC

Graham Storey 01869 238380

David Kleeman 020 7430 9329

 

Hybridan LLP - Financial adviser and Broker

Claire Noyce/Tim Goodman /Deepak Reddy- 020 7947 4350

 

Brewin Dolphin - Nominated Adviser

Neil Baldwin 0845 213 4730

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAAFASXFFFF
Date   Source Headline
10th May 20244:50 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company
26th Sep 20233:37 pmRNSDirector/PDMR Shareholding
25th Sep 202311:00 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSFinal Results & Investor Presentation
22nd Sep 20239:25 amRNSHolding(s) in Company
31st Aug 20235:00 pmRNSTotal Voting Rights
29th Aug 20238:30 amRNSTransaction in Own Shares & TVR
23rd Aug 20237:00 amRNSNotice of Results & Investor Presentation
16th Aug 202310:03 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSYear End Trading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20234:24 pmRNSTransaction in own shares & TVR
19th Jun 20234:29 pmRNSHolding(s) in Company
16th Jun 20235:57 pmRNSTransaction in own shares & TVR
5th Jun 20237:00 amRNSSAW: Extension of scope of licence agreement
2nd Jun 20232:36 pmRNSTransaction in own shares & TVR
31st May 20235:00 pmRNSTotal Voting Rights
3rd May 20237:00 amRNSNew Automotive eDrive Business Contract
2nd May 202312:48 pmRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.